Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,069.80 +51.41 (+1.02%) Dow
38,251.90 +348.61 (+0.92%) Nasdaq
15,857.55 +252.07 (+1.62%) Bitcoin USD
59,165.88 +867.18 (+1.49%) CMC Crypto 200
1,276.98 +6.24 (+0.49%)
NVO May 2024 80.000 call
| Previous close | 44.05 |
| Open | 44.05 |
| Bid | 43.85 |
| Ask | 45.90 |
| Strike | 80.00 |
| Expiry date | 2024-05-17 |
| Day's range | 44.05 - 44.05 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
Yahoo FinanceNovo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
- Yahoo Finance Video
Apple, Novo Nordisk earnings, jobless claims: What to watch
A number of companies release their quarterly earning reports on Thursday, including Apple (AAPL), Novo Nordisk (NVO), Shell (SHEL), ConocoPhillips (COP), Cigna (CI), Coinbase (COIN), Moderna (MRNA), DraftKings (DKNG), Kellanova (K), United States Steel (X), and more. On the economic front, jobless claims for the week ending on April 27 will be released. Economists expect claims to rise to 212,000 from 207,000 the prior week. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Nicholas Jacobino
Barrons.comNovo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.
The Danish pharmaceutical firm, Europe’s most valuable company, said sales of the weight-loss drug jumped 106% in the first quarter.
